Junevity has engaged Sunrise BioVentures as advis
Author: Michael
New collaboration shifts the focus from slowing
The company’s latest platform update brings FD
Immorta Bio says the future of medicine may lie
C2N Diagnostics and SouthGenetics aim to bring e
Researchers from across disciplines will gather
Alterity Therapeutics reported a successful End-o
Houston-based Coya Therapeutics has started the b
AlzeCure has entered a collaboration and out-lice
MetaVia presented late-breaking Phase 1 and precl